Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998; 116: 716–730.
Murkin JM. Attenuation of neurologic injury during cardiac surgery. Ann Thorac Surg 2001; 72: S1838–S1844.
Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232–244.
del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland Br, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22: 1276–1283.
Mori E, del Zoppo GJ, Chambers D, et al. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992; 23: 712–718.
Jansen P, Baufreton C, Besnerais P, et al. Heparin coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 1363–1366.
Lord RA, Roath OS, Thompson JF, Chant AD, Francis JL. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 1992; 79: 517–521.
Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993; 106: 1–10.
Asimakopoulos G, Lidington EA, Mason J, O'Haskard D, Taylor KM, Landis RC. Effect of aprotinin on endothelial activation. J Thorac Cardiovasc Surg 2001; 122: 123–128.
Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg 1994; 58: 146–153.
Kamiya T, Katayama Y, Kashiwagi F, Terashi A. The role of bradykinin in mediating ischaemic brain edema in rats. Stroke 1993; 24: 571–576.
Gurevitch J, Barak J, Hochhauser E, Paz Y, Yakirevich V. Aprotinin improves myocardial recovery after ischemia and reperfusion. Effects of the drug on isolated rat hearts. J Thorac Cardiovac Surg 1994; 108: 109–118.
Carlos TM, Harlan JM. Leukocyte-endothelial cell adhesion molecules. Blood 1994; 84: 2068–2101.
Scannell G, Waxman K, Vazira ND, et al. Hypoxia-induced alterations of neutrophil membrane receptors. J Surg Res 1995; 59: 141–145.
Mataki H, Inagaki T, Yokoyama M, Maeda S. ICAM-1 expression and cellular injury in cultured endothelial cells under hypoxia/reoxygenation. Kobe J Med Sci 1994; 40: 49–63.
Clark ET, Desai TR, Hynes KL, Gewertz BL. Endothelial cell response to hypoxia–reoxygenation is mediated by IL-1. J Surg Res 1995; 58: 675–681.
Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1A. An autocrine mechanism promoting expression of leukocyte adhesion molecules on vessel surface. J Clin Invest 1992; 90: 2333–2339.
Asimakopoulos G, Thompson R, Nourshargh S, et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 2000; 120: 361–369.
Sethi S, Singh MP, Dikshit M. Nitric oxide mediated augmentation of polmorphonuclear free radical generation following hypoxia–reoxygenation. Blood 1999: 93; 333–340.
Wellicome SM, Thornhill MH, Pitzalis C, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990; 144: 2558–2565.
Wang X, Feuerstein GZ. Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma 1995; 12: 825–832.
Zhang W, Smith C, Howlett C, Stanimirovic D. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1β. J Cereb Blood Flow Metab 2000; 20: 967–978.
Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G. Serum levels of IL-1, IL-6 and tumor necrosis factor in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89: 255–260.
Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effects of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25–30.
Fujiwara T, Seo N, Murayama T, Hirata S, Kawahito K, Kawakami M. Transient rise in serum cytokines during coronary artery bypass graft surgery. Eur Cytokine Netw 1997; 8: 61–66.
Cole DJ, Patel PM, Schell RM, Drummond JC, Osborne TN. Brain ecosanoid levels during temporal focal cerebral ischaemia in rats: a microdialysis study. J Neurosurg Anesthesiol 1993; 5: 41–47.
Kontos MA. Oxygen radicals in cerebral ischaemia. In: Ginsberg MD, Dietrich WD, eds. Cerebovascular Diseases: 16th Princeton Conference. New York: Raven Press, 1989: 365–372.
Ames A, Wright L, Masayoshi K, Thurston J, Majino G. Cerebral ischemia: The no-reflow phenomenon. Am J Pathol 1968; 52: 437–443.
Jean W, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after focal ischaemia: the role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43: 1382–1396.
Pruefer D, Makowski J, Dahm M, et al. Aprotinin inhibits leukocyte–endothelial cell interactions after hemorrhage and reperfusion. Ann Thorac Surg 2003; 75: 210–215.
Sunamori M, Sultan I, Suzuki A. Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion. Ann Thorac Surg 1991; 52: 971–978.
Scannell G. Leukocyte responses to hypoxic/ischemic conditions. New Horiz 1996; 4: 179–183.
Chakraborti T, Ghosh SK, Michael JR, Chakraborti S. Role of an aprotinin-sensitive protease in the activation of Ca(2+)-ATPase by superoxide radical (O−2) in microsomes of pulmonary vascular smooth muscle. Biochem J 1996; 317: 885–890.
Nagahiro I, White T, Yano M, et al. Recombinant Kunitz protease inhibitor ameliorates reperfusion injury in rat lung transplantation. Ann Thorac Surg 1998; 65: 66–69.
Tamura K, Manabe T, Imanishi K, et al. Effects of synthetic protease inhibitors on superoxide (O−2), hydrogen peroxide (H2O2) and hydroxyl radical production by human polymorphonuclear leukocytes. Hepato-gastroenterology 1992; 39: 59–61.
Fearon DT, Collins LA. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 1983; 130: 370–375.
Barry MC, Wang JH, Kelly CJ, et al. Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. Eur J Vasc Endovasc Surg 1997; 13: 381–387.